Target intelligence / Profile preview

Milk fat content (MFC)

Target
MFC
Molecular classification
Other
01

Overview

Milk fat content refers to the concentration of lipids, predominantly triacylglycerols (approximately 98%), secreted in mammalian milk during lactation [2, 14]. It is not a single molecular target but a complex phenotypic trait regulated by a coordinated network of enzymes such as Diacylglycerol O-acyltransferase 1 (DGAT1), Fatty Acid Synthase (FASN), and Stearoyl-CoA Desaturase (SCD), as well as hormonal signaling through the JAK2/STAT5 pathway [3, 6, 7]. In the agricultural sector, milk fat content is a primary target for genetic selection and nutritional management to optimize the energy density and manufacturing properties of dairy products [13]. In human health, the consumption of milk with varying fat content is a significant dietary factor linked to metabolic outcomes, cardiovascular health, and the delivery of bioactive lipids like conjugated linoleic acid (CLA) [9, 11]. Interventions such as the administration of specific CLA isomers or bovine somatotropin (bST) can significantly modulate milk fat synthesis by altering the expression of lipogenic genes or shifting nutrient partitioning in mammary epithelial cells [12, 14].

Other names
Milk fat percentageMilk lipid concentrationMilk fat yieldMilk fat proportion
02

Mechanism of action

Modulation of milk fat content is achieved through the inhibition of lipogenic gene expression (e.g., trans-10, cis-12 CLA downregulating FASN and SCD via SREBP1 suppression), hormonal stimulation of mammary metabolic activity (e.g., somatotropin increasing nutrient uptake), or the alteration of rumen microbial fermentation to change the availability of fatty acid precursors (e.g., monensin increasing propionate production).

03

Biological functions

LactationLipid metabolismNutrient secretionEnergy transfer to offspring
04

Disease associations

Metabolic disorders (e.g., Ketosis in cattle)Obesity (human dietary context)Cardiovascular disease (human dietary context)Diabetes mellitus (human dietary context)
05

Safety considerations

Negative energy balance in high-producing animalsMetabolic stress (Ketosis)Altered nutritional profile for human consumptionPotential for reduced milk flavor and processing quality
06

Interacting drugs

Conjugated linoleic acid

2 more in the full profile.

07

Biomarkers

DGAT1 K232A polymorphismMilk fatty acid profileBlood beta-hydroxybutyrate (BHBA) levelsTriglyceride concentration

Beyond the preview

Go deeper on Milk fat content (MFC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Milk fat content (MFC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call